Re-Vana Therapeutics is a drug delivery company focused on the treatment of chronic eye diseases such as AMD, DR, DME, & Glaucoma. Proud
@MassChallengeUK Winner
@MassChallengeUK Winner
Location: United Kingdom, Ulster, Belfast
Employees: 11-50
Total raised: $11.9M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Techstart ... | techstart.... |
| - | Visionary ... | visionaryv... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.11.2022 | Series A | $11.9M | - |
Mentions in press and media 5
| Date | Title | Description |
| 20.03.2024 | Belfast’s tech scene is booming: Here are 7 dynamic startups taking the city by storm in 2024 | Read this article in: Belfast is on the fast track to becoming a tech hub with its significant rise in the Global Startup Ecosystem Index. The capital of Northern Ireland currently hosts multiple thriving startups. This growth is attributed... |
| 30.11.2022 | Re-Vana Therapeutics Raises USD11.9M in Series A Funding | Re-Vana Therapeutics Ltd, a Belfast, Northern Ireland, UK-based specialty drug delivery company developing sustained-release therapeutics for the treatment of vision-threatening ocular diseases, closed its Series A round with $11.9m in fund... |
| 06.10.2020 | Re-vana Therapeutics delivers $3.2 Million oversubscribed round | ExSight Ventures ("ExSight") is pleased to announce our investment Re-Vana Therapeutics, Ltd, ("Re-Vana") to support pre-clinical development of sustained-release biologic and small molecule therapeutics. ExSight is prou... |
| 02.06.2020 | Re-Vana Therapeutics Raises $3.25M in Pre-Series A Financing | Re-Vana Therapeutics Ltd, a Belfast, Northern Ireland-based specialty therapeutic and drug delivery company developing sustained-release therapeutics for sight-threatening ocular diseases, closed a $3.25m pre-Series A financing. The round w... |
| - | Re-Vana Therapeutics | “Home - Re-Vana: Vision In The Future” |